Home - Products - GPCR/G Protein - Antibacterial - 6-Chloro-7-deazapurine-β-D-riboside

6-Chloro-7-deazapurine-β-D-riboside

CAS No. 16754-80-6

6-Chloro-7-deazapurine-β-D-riboside( —— )

Catalog No. M28127 CAS No. 16754-80-6

6-Chloro-7-deazapurine-β-D-riboside shows antifungal activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 35 In Stock
50MG 50 In Stock
100MG 72 In Stock
200MG 106 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    6-Chloro-7-deazapurine-β-D-riboside
  • Note
    Research use only, not for human use.
  • Brief Description
    6-Chloro-7-deazapurine-β-D-riboside shows antifungal activity.
  • Description
    6-Chloro-7-deazapurine-β-D-riboside shows antifungal activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    β-Lactamase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    16754-80-6
  • Formula Weight
    285.68
  • Molecular Formula
    C11H12ClN3O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (350.04 mM)
  • SMILES
    OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1ccc2c(Cl)ncnc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.David T Davies, et al. Discovery of ANT3310, a Novel Broad-Spectrum Serine β-Lactamase Inhibitor of the Diazabicyclooctane Class, Which Strongly Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacterales and Acinetobacter baumannii. J Med Chem. 2020 Dec 24;63(24):15802-15820.
molnova catalog
related products
  • Contezolid

    Contezolid (MRX I) is an orally active oxazolidinone agent with antibacterial activity Gram-positive pathogens, including MRSA, penicillin-PRSP, PISP, and vancomycin-resistant enterococci (VRE) with MIC of 0.25-4 ug/mL.

  • QcrB inhibitor TB47

    QcrB inhibitor TB47 (TB47) is a novel antimycobacterial agent that fuctions as a putative respiratory complex III (QcrB) inhibitor with MIC of 0.016-0.5 ug/mL against a panel of 56 M.

  • SPI009

    SPI009 is a novel antipersister compound active against P. aeruginosa.